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A chromatographic technique for determination of rutin and narcissin in marigold extract and topical formulations was developed and 
validated.  The method shows linearity over the concentration range of 0.2 – 6.0 mg/mL of rutin (r = 0.9986) and 0.8 – 12.0 µg/mL of 
narcissin (r = 0.9951). The values obtained for precision and accuracy are in agreement with ICH guidelines. Both the formulation 
excipients and the porcine ear skin samples did not interfere with the flavonoids determination. The recovery of rutin and narcissin in 
skin samples added with marigold extract was 81.41% and 83.35%, respectively, which demonstrate the applicability of this method 
to perform skin penetration studies.
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INTRODUCTION
Calendula officinalis L. (Asteraceae) is an annual herb native to 
the Mediterranean region. In Europe and America it is cultivated for 
ornamental and medicinal purposes. It is commonly known as the 
marigold or maravilla, and its flowers have been applied in many 
medicinal preparations such as unguents, tinctures, dental gels, etc.1,2
Phytopharmacological studies of different marigold extracts 
have shown anti-viral, anti-HIV,3 anti-tumoral,4 anti-genotoxic5 and 
antioxidant activities.6-8 In addition, marigold flowers have shown 
anti-inflammatory and wound healing properties.9-11 In clinical studies, 
marigold was highly efficacious in the prevention of acute dermatitis 
in cancer patients undergoing postoperative irradiation.12
Chemical constituents of Calendula officinalis include some 
triterpene saponins,  triterpene alcohols,1 triterpene esters,13 carotenoi-
ds,14,15 flavonoids (quercetin, rutin, isorhamnetin and kaempferol),16 
coumarins, essential oil, malic acid, mucilage, resin, tannin, sterols, 
among others.1,17 
In recent years, there has been renewed interest in natural medi-
cines that are obtained from plant parts or plant extracts. However, 
the idea that herbal drugs are safe and free from side effects is false. 
Plant extracts are biological materials and exhibit natural variations 
in composition, due to factors such as season, geography and cultivar 
that can greatly affect the quality and consequently the therapeutic 
value of herbal medicines.18 Therefore, it is very important to establish 
quality control parameters to insure their efficacy and safety.
The flavonoids, rutin and narcissin, were selected as chemical 
marker of marigold extract because flavonoids are a widespread group 
of natural products. Moreover, in recent years a lot of biochemical and 
pharmacological properties of vegetable extracts have been related 
to flavonoid content.19
In this study, a reverse phase- high performance liquid chro-
matography (RP-HPLC) technique for determination of rutin and 
narcissin in marigold extract was developed and validated. In addi-
tion, the applicability of this method in in vitro retention studies of 
topical formulations added with this extract was investigated. The 
results demonstrated that the developed method is a fast and reliable 
HPLC technique for determination of rutin and narcissin in topical 
formulations added with marigold extract and to perform in vitro 
skin penetration studies.  
EXPERIMENTAL
Chemicals
The Calendula officinalis L. dried flowers were a gift from San-
tos Flora (Sao Paulo, SP, Brazil). Rutin (95%) was purchased from 
Sigma-Aldrich (St Louis, MO, USA). Narcissin (99%) was purchased 
from Chromadex (Ivine, CA, USA). Acetic acid of chromatographic 
grade was supplied by Merck (Darmstadt, Germany). Acetonitrile 
(ACN) and methyl alcohol (MeOH) for use in chromatography and 
spectrophotometry were purchased from J. T. Baker (USA). The 
water used to prepare the solutions or mobile phase was purified in 
a Milli-Q-plus System (MilliporeÒ, Bedforte, MA, USA). Chloroform 
was supplied by Mallinckrodt Baker (Paris, France). Ethyl alcohol 
was supplied from Synth (Sao Paulo, Brazil). All the raw materials 
for the formulations were purchased from Galena (Campinas, SP, 
Brazil) or Clariant (Sao Paulo, SP, Brazil). 
Preparation of marigold extract
The Calendula officinalis L. dried flowers were ground in a knife 
mill into fine particles (0.3 mm - mean diameter). The powdered drug 
was macerated with 50% ethanol (1:9, w/w) at 25 °C for 5 days.  This 
mixture was submitted to mechanical stirring at 870 rpm (Fisatom, 
model 713 D) for 1 h at the beginning and end of the maceration 
period. Afterwards, the extract was filtered and dried at 40 °C in a 
stove with air circulation. Finally, the residue was dissolved into 50% 
hydroalcoholic solution (200 mL) and stored at -20 °C.  The extract 
obtained by this procedure presented 15.7% dry weight. 
Determination of rutin and narcissin by HPLC
Apparatus and chromatographic conditions
The rutin and narcissin levels in marigold extract were deter-
mined using a Shimadzu (Kyoto, Japan) liquid chromatograph 
system equipped with an LC-10 AT VP solvent pump unit and an 
SPD-10A VP UV-Visible detector operating at 340 nm. Samples 
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were injected manually through a rheodyne injector (20 mL loop). 
Separation was performed in a BDS Hypersyl C18 column (250 x 
4.6 mm, 5 mm) (Part. n° 28105-254630) (Thermo electron corpora-
tion, USA), equipped with a precolumn BDS Hypersyl C18 (10 x 4 
mm, 5 µm) (Thermo electron corporation, USA). The mobile phase 
was acetonitrile–water (15:85, v/v) containing 2% (v/v) acetic acid 
at a flow rate of 1 mL/min. Data were collected using a chromatopac 
C-R6A integrator (Shimadzu, Kyoto, Japan).
Validation
Validation was performed following the ICH guidelines.20 The 
method was validated considering the parameters linearity, accuracy, 
precision, limit of detection and limit of quantitation. 
Linearity was checked with standard solutions of rutin in the 
concentration range of 0.2-6.0 mg/mL and narcissin in the concentra-
tion range of 0.8-12.0 µg/mL. The standard curves were analyzed by 
linear regression of peak area versus narcissin or rutin concentration. 
Precision was expressed as relative standard deviation (RSD %) 
and was determined by repeatability (intra-day) and intermediate 
precision (inter-day). Repeatability was evaluated by analysis of six 
replicates in the same day under the same experimental conditions. 
The intermediate precision was studied by assaying 6 replicates on 
3 different days.
The accuracy experiments applied the standard addition method 
(rutin and narcissin) in the sample (marigold extract), using replicates 
(n = 3) of three different rutin and narcissin concentrations. 
For that, the marigold extract solution was prepared by dilution 
of 100 mL of concentrated extract (15.7% dry weight) into 10 mL of 
50% methanolic solution. Next, 8 mL of this solution were diluted into 
25 mL of mobile phase, being detected a final rutin concentration of 
0.91 mg/mL. This Marigold extract solution (5 mL) was spiked with 
three different volumes (1, 2 and 3 mL) of rutin standard solution (2.0 
mg/mL) and diluted once more (10 mL), obtaining rutin theoretical 
final concentrations of 0.66, 0.86 and 1.06 µg/mL. 
In the accuracy experiments of narcissin content, the marigold 
extract solution was prepared by dilution of 100 mL of concentrated 
extract into 10 mL of 50% methanolic solution (18.3 µg/mL). Next, 
500 µL of this solution and 0.6, 1.0 and 1.4 mL narcissin standard 
solution (10 µg/mL) were diluted into 5 mL of mobile phase. Then, 
narcissin theoretical final concentrations obtained in each solution 
were of 3.04, 3.84 and 4.64 µg/mL.
Finally, the solutions were filtered and analyzed by the developed 
HPLC method. Accuracy was expressed as percent of recovery, which 
was estimated as the relation between the experimental concentrations 
and the theoretical concentrations ((C
e
/Ct) x 100).
The detection limit (LD) and quantitation limit (LQ) were deter-
mined on the basis of the standard deviation of the response and the 
slope of the constructed calibration curve. The LD was expressed as 
(3.3 x Ò)/S and, the LQ was expressed as (10 x Ò)/S, where Ò is the stan-
dard deviation of the response and S is the slope of calibration curve.
Method application
Formulations
Topical formulations were developed using two different self-
emulsifying agents and one polymer, as it can be seen in Table 1. 
Formulation 1 (gel-cream) was prepared using the self-emulsifying 
agent Hostacerin SAF® and formulation 2 (cream) using the commer-
cially available self-emulsifying wax Polawax®, isodecyl oleate and 
isopropyl palmitate as emollient and glycerol as a moisturizer. The 
preservatives used for F1 and F2 were a mixture of phenoxyethanol 
and parabens, previously dissolved in propylene glycol and then 
incorporated into the formulations at room temperature. Formulation 
3 (gel) was prepared using the nonionic polymer Natrosol 250HHR®, 
hyaluronic acid as a moisturizer and polyoxyethylene (20) sorbitan 
monolaurate and ethyl alcohol as co-solvent. The preservative used 
for F3 was DMDM hydantoin (1,3-Dimethylol-5,5-dimethylhydan-
toin glydant), previously dissolved in propylene glycol and then 
incorporated into the formulations at room temperature. Water was 
replaced for Mcllvaine buffer (0.2 M disodium hydrogen phosphate 
and 0.1 M citric acid, pH 6.0) in the preparation of all formulations. 
Marigold extract (5%, w/w) was incorporated to the formulations at 
room temperature, 24 h after its preparation. Control formulations 
were prepared without the extract (C1, C2 and C3).
Rutin and narcissin content in marigold extract and topical 
formulations 
The developed method was used for determination of rutin and 
narcissin content in marigold extract and topical formulations. 
For that, marigold extract solutions were prepared by dilution 
of 100 mL of concentrated extract into 10 mL of 50% methanolic 
solution. Next, 1 mL of this solution was diluted into 5 mL of mobile 
phase. Finally, this solution was filtered and analyzed by HPLC. 
Formulation samples were diluted into 50% hydroalcoholic 
solution (1:9, w/w). Then, 2 mL of this solution were added to 2 mL 
of chloroform. This mixture was submitted to mechanical stirring 
(Ika® works, model MS 1) at 2500 rpm for 1 min and centrifuged 
(Excelsa Baby I, model 206-R) at 3000 rpm for 10 min. 400 µL of 
aqueous phase were diluted in 600 µL of mobile phase, filtered and 
analyzed by HPLC.
Rutin and narcissin recovery in pig skin samples
Known concentrations of the marigold extract were applied to 
the skin and further submitted to the extraction procedure, as descri-
bed by Wagner and collaborators,21 who evaluated the recovery of 
sesquiterpene lactones in skin retention study.
Then, to conduct this study the skin from the outer surface of 
an excised porcine ear was used. Pig ears were obtained within 2 h 
after slaughter of the animals. The whole skin membrane was then 
carefully removed from the underlying cartilage with the help of a 
Table 1. Percent composition (w/w) of the formulations
Components F 1 F 2 F 3 C 1 C 2 C 3
Hostacerin SAF®a 6 - - 6 - -
Polawax®b - 8 - - 8 -
Natrosol 250HHR®c - - 1.5 - - 1.5
Isodecyl oleate - 2 - - 2 -
Isopropyl palmitate - 1.5 - - 1.5 -
Glycerol - 3 - - 3 -
Phenoxyethanol and parabens 0.5 0.5 - 0.5 0.5 -
DMDM hydantoind - - 0.4 - - 0.4
Propylene glycol 5 5 10 5 5 10
Ethanol - - 30 - - 30
Polyoxyethylene (20) sorbitan 
monolaurate - - 1 - - 1
Hyaluronic acid 1% - - 1 - - 1
Mcllvaine buffere 88.5 80 56.1 88.5 80 56.1
Marigold extract 5 5 5 - - -
a
 Self-emulsifying was prepared without heating (ammonium acryloyldi-
methyl-taurate/VP copolymer+rapessed oil sorbitol esters+trilauril-4 
phosphate+mineral oil+isopropyl palmitate); b self-emulsifing wax (alcohol 
cetoesteariliric and sorbitan monostearate 20 OE); c polymer nonionic 
(ultrahigh-molecular-weight hydroxyethylcellulose); d 1,3-Dimethylol-5,5-
dimethylhydantoin glydant; e 0.2 M disodium hydrogen phosphate and 0.1 
M citric acid, pH 6.0.
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scalpel. The subcutaneous tissues were removed and the skin stored 
at -20 °C for a maximum period of 30 days before use.22
Firstly, skin sections (area of 1.77 cm2) were subjected to tape strip-
ping to remove the stratum corneum (SC) from the remaining epidermis 
(E) and dermis (D) [E+D]. For this procedure, 15 tapes were successive 
stripped (invisible tape) on the skin sections. Secondly, the remaining 
[E+D] was added with the same concentration of marigold extract pres-
ent in 500 mg of formulation (25 mL). Then, this skin sections were cut 
in small pieces, homogenized in 50% methanolic solution (2 mL) using 
turratec homogeneitor (Tecnal, model TE-102) at 20500 rpm for 2 min. 
This mixture was led to ultra-sound for 15 min, mixed in vortex (Phoenix, 
model AP56) for 1 min, and centrifuged for 15 min at 1660 g. After the 
centrifugation, the supernatant was filtered (0.45 mm filter, MilliporeÒ, 
Brazil) and placing it in a second test-tube. The supernatant was evapo-
rated to dryness under air-flow and reconstituted into 50% methanolic 
solution (500 µL). Then, 100 µL of this solution were diluted in 400 µL 
of mobile phase, filtered and analyzed by HPLC, as described above. 
The same procedure was done by skin samples without previ-
ous addition of Marigold extract in order to evaluate if the skin 
constituents might interfere with rutin and narcissin detection by the 
developed method using HPLC.
The absolute recovery of rutin and narcissin extracted from skin 
layers was determined considering the Equation below:
                      Recovery (%) =   Ce   x 100
                                                   Ci
where, Ce = represents the experimental concentration of rutin or 
narcissin obtained after extraction procedure and Ci = represents the 
initial concentration of rutin or narcissin present in marigold extract 
added to the skin before the extraction procedure.
RESULTS AND DISCUSSION
In the present work, RP-HPLC with UV detection and isocratic 
mobile phase mode was proposed as a suitable method for quantita-
tive determination of rutin and narcissin in marigold extract (Figure 
1). In addition, the applicability of this method in in vitro retention 
studies of topical formulations added with this extract was suggested.
The chromatographic analysis developed for quantitative deter-
mination of these flavonoids was validated according to ICH guide-
lines,20 to obtain reproducible analyses with high degree of accuracy 
and precision in the range of concentrations investigated.
Under the experimental conditions, the linearity was maintained 
within the concentration range considered. A regression analysis 
was performed, with the observation of the good linearity and the 
representative linear equation was y = 15100x - 1746 for rutin and 
y = 20390x + 477.3 for narcissin.  Table 2 summarizes the results of 
the regression analysis and shows the slope, intercept and correlation 
coefficient for each calibration range. The correlation coefficients for 
all the calibration curves were all close to 0.99.
The repeatability and intermediate precision were determined by 
performing 6 replicate analyses of the extract samples and evaluated 
by RSD of the peak area of rutin or narcissin. The mean of peak 
area, rutin or narcissin content and the relative standard deviation 
are reported in Table 3.
The accuracy of the method was determined by adding known 
amount of rutin and narcissin standard in known marigold extract 
samples at 3 levels of concentration. The mean values of the percen-
tage analytical recoveries for the concentration of 0.66, 0.86 and 1.06 
µg/mL of rutin were 97.98, 100 and 103.46%, respectively. The mean 
values of the percentage analytical recoveries for the concentration 
of 3.04, 3.84 and 4.64 µg/mL of narcissin were 90.46, 95.83 and 
103.45%, respectively (Table 4).
The values obtained for precision and accuracy determination 
are in agreement with accepted validation produced, which indicates 
that the chromatographic conditions used is reliable to quantify both 
flavonoids in the range evaluated.
The detection limit of rutin and narcissin were 0.12 and 0.48 µg/
mL, respectively and the quantitation limit of rutin and narcissin were 
0.37 and 1.45 µg/mL, respectively. 
Figure 1. Structures of the rutin and narcissin 
Table 2. Linearity of rutin and narcissin in the HPLC analysis
Concentration  
range (µg/mL) Slope Intercept r
Rutin 0.2 – 6.0 15100 ± 197.3 -1746  ± 560.3 0.9986
Narcissin 0.8 – 12.0 20390 ± 475.4 477.3 ± 2948 0.9951
The results are mean ± SD of three experiments; r – Correlation coefficient.
Table 3. Precision of HPLC method for quantitation of rutin and narcissin 
in marigold extract
Peak area RSD  (%)
Rutin  
(mg/mL)
RSD 
(%)
Intra-day precisiona 5819 ± 293.36 5.04 237.21 ± 10.40 4.38
Inter-day precisionb 5998 ± 231.18 3.85 236.27 ± 6.45 2.73
Peak area RSD  (%)
Narcissin  
(µg/mL)
RSD  
(%)
Intra-day precisiona 75862 ± 2102 2.77 1860 ± 50.0 2.78
Inter-day precisionb 72847 ± 3909 5.37 1830 ± 70.0 3.65
The results are mean ± SD of 6 determinations. a  6 replicates were assayed 
on the same day; b 6 replicates were assayed on 3 different days.
Table 4. Accurancy of the HPLC method
Rutin added 
(mg/mL)
Rutin found 
(mg/mL)
Recovery 
(%)
A 0.66 0.65 ± 0.01 97.98 ± 0.87
B 0.86 0.86 ± 0.01 100.00 ± 1.16
C 1.06 1.09 ± 0.02 103.46 ± 1.44
Narcissin added 
(mg/mL)
Narcissin found 
(mg/mL)
Recovery 
(%)
A 3.04 2.75 ± 0.44 90.46 ± 14.96
B 3.84 3.68 ± 0.21 95.83 ± 5.88
C 4.64 4.80 ± 0.53 103.45 ± 11.44
A - Low concentration, B – intermediate concentration and C – high concen-
tration for range calibration. The results are mean ± SD of 3 experiments.
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as showed in Table 5, were 103.4, 92.32 and 81.60% for F1, F2 and 
F3, respectively. The recoveries of narcissin in formulations added 
with marigold extract were 92.95, 109.05 and 108.15% for F1, F2 
and F3, respectively. Therefore, the proposed method was specific and 
selective for rutin and narcissin incorporated in these formulations 
once the formulations components caused no interference with the 
rutin and narcissin determination. Besides this, the developed HPLC 
methodology could be used to perform the quality control of these 
three different formulations added with marigold extract.
In the evaluation of the applicability of this method for determination 
of rutin and narcissin in skin samples, it was observed that chromatogra-
phic profiles of rutin, narcissin and others compounds (retention time and 
area) were not affected by the biological matrices (Figure 3). In addition, 
the recovery of rutin in skin samples added to marigold extract was 
81.41% and narcissin was 83.35% (Table 6). Therefore, the combined 
procedures for extraction and HPLC assay of rutin and narcissin in skin 
samples is efficient in terms of recovery and fast manipulation.
The applicability of this method for determination of rutin and 
narcissin in topical formulations added with marigold extract was also 
investigated. For that, blank samples of formulations (C1, C2 and C3) 
were evaluated in relation to the chromatographic characteristics (peaks 
presence and retention time). The blank samples of formulations did not 
show any interference regards to the chromatographic characteristics 
(data not shown). In the presence of excipients, the chromatographic 
profiles of rutin, narcissin and others compounds (retention time and 
area) were not affected. Figure 2 shows the chromatogram of topical 
formulations added with marigold extract and the extract alone. 
The recovery of rutin in formulations added with marigold extract, 
Table 5. Rutin and narcissin concentration in marigold extract and recovery 
in topical formulations added with this extract
Rutin 
(µg/g)
Concentration 
added 
Concentration 
found 
Recovery 
(%)
F 1 12.50 12.88 ± 0.73 103.04
F 2 12.50 11.54 ± 1.00 92.32
F 3 12.50 10.20 ± 0.81 81.60
Extract 
(µg/g) - 239.0 ± 1 3.2 -
Narcissin 
(µg/g)
Concentration
 added 
Concentration 
found 
Recovery 
(%)
F 1 95.67 88.93 ± 16.9 92.95
F 2 95.67 104.32 ± 11.8 109.05
F 3 95.67 103.47 ± 6.3 108.15
Extract 
(µg/g) - 1910 ± 70.0 -
The results are mean (n=3) ± Std. Error of  3 experiments.
Figure 2. Typical chromatogram of marigold extract and topical formulations 
added with marigold extract. A: marigold extract, B: F 1, C: F 2 and D: F 3 
Figure 3. Recovery of rutin and narcissin extracted from skin layers. A: skin 
sample without marigold extract and B: skin sample with marigold extract
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Table 6. Recovery of rutin and narcissin extracted from skin layers
Rutin Narcissin
Concentration added (mg)a 7.12 45.90
Concentration found (mg) 5.80 ± 0.50 38.26 ± 0.78
Recovery (%) 81.41 ± 6.97 83.35 ± 1.69
a Rutin and narcissin concentration in 25 µL of marigold extract added to 
skin samples. The results are mean ± SD of 3 experiments.
The extraction procedures accomplished for preparation of the 
samples in studies of recovery in topical formulations and skin sam-
ples do not significantly affect the recovery of rutin and narcissin. 
These extraction procedures showed to be effective for determination 
of both flavonoids in biological and pharmaceutical matrices.
CONCLUSION
Concluding, the present work developed a fast and reliable HPLC 
technique for determination of rutin and narcissin in topical formu-
lations added with marigold extract. Moreover, the high recovery of 
rutin and narcissin from porcine ear skin samples demonstrate that 
the method reported could successfully be applied in in vitro skin 
penetration studies of topical formulations added with this extract. 
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